Related Experiment Video
Updated: Jun 9, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA dysregulation in gastric cancer: a new player enters the game
1Department of Medicine and Therapeutics, Institute of Digestive Diseases, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, PR China.
Abstract:
Gastric carcinogenesis is a multistep process involving genetic and epigenetic alteration of protein-coding proto-oncogenes and tumor-suppressor genes. Recent discoveries have shed new light on the involvement of a class of noncoding RNA known as microRNA (miRNA) in gastric cancer. A substantial number of miRNAs show differential expression in gastric cancer tissues. Genes coding for these miRNAs have been characterized as novel proto-oncogenes and tumor-suppressor genes based on findings that these miRNAs control malignant phenotypes of gastric cancer cells. In this connection, miRNA dysregulation promotes cell-cycle progression, confers resistance to apoptosis, and enhances invasiveness and metastasis. Moreover, certain polymorphisms in miRNA genes are associated with increased risks for atrophic gastritis and gastric cancer, whereas circulating levels of miRNAs may serve as biomarkers for early diagnosis. Several miRNAs have also been shown to correlate with gastric cancer progression, and thus may be used as prognostic markers. Elucidating the biological aspects of miRNA dysregulation may help us better understand the pathogenesis of gastric cancer and promote the development of miRNA-directed therapeutics against this deadly disease.
Insights
MicroRNAs (miRNAs) play a crucial role in gastric cancer development by regulating cell growth and spread. Understanding miRNA dysregulation offers new diagnostic and therapeutic strategies for this disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric carcinogenesis involves genetic and epigenetic changes in key genes.
- MicroRNAs (miRNAs), a class of noncoding RNA, are increasingly recognized for their role in cancer.
- Differential expression of miRNAs in gastric cancer tissues suggests their involvement in tumorigenesis.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in the pathogenesis of gastric cancer.
- To explore the potential of miRNAs as diagnostic and prognostic biomarkers for gastric cancer.
- To understand how miRNA dysregulation contributes to malignant phenotypes in gastric cancer cells.
Main Methods:
- Analysis of differential miRNA expression in gastric cancer tissues.
- Characterization of miRNA genes as novel proto-oncogenes and tumor-suppressor genes.
- Investigation of miRNA polymorphisms and their association with gastric cancer risk.
Main Results:
- A significant number of miRNAs are differentially expressed in gastric cancer.
- miRNA dysregulation promotes cell-cycle progression, apoptosis resistance, invasiveness, and metastasis.
- Certain miRNA gene polymorphisms are linked to increased risk of atrophic gastritis and gastric cancer.
- Circulating miRNAs show potential as early diagnostic and prognostic markers.
Conclusions:
- MicroRNAs are critical regulators in gastric cancer development and progression.
- Dysregulated miRNAs can be considered novel oncogenes or tumor suppressors in gastric cancer.
- miRNAs hold promise as biomarkers for early diagnosis and prognosis, and as therapeutic targets.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Gastritis II: Pathophysiology
Abnormal Proliferation